You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab′)2: pharmacokinetics, tissue distribution, and tumor imaging

Citation Tools

Article menu
Download PDFPDF
Original Articles
Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab′)2: pharmacokinetics, tissue distribution, and tumor imaging

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
BUIST MR, KENEMANS P, VERMORKEN JB, et al
Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab′)2: pharmacokinetics, tissue distribution, and tumor imaging
International Journal of Gynecologic Cancer 1992;2:23-34.